I AM BIO Biotechnology Innovation Organization

This is the I Am BIO minisode, where we bring you a full interview from Monday's episode complete and unfiltered. In this minisode, we share the conversation we had with Dr. Reed Tuckson, founder of the Black Coalition Against COVID-19. Check out the full episode Voices of Vaccine Hesitancy here: https://iambio.simplecast.com/episodes/voices-of-vaccine-hesitancy

Vaccines are the biggest thing on everyone’s mind right now. Whether there is hesitancy or people scrambling to get their two doses, the question is how to get 80% of adults to get the shots? In this episode, we dissect people’s fears and connect with a community leader who is trying to educate people and also make sure everyone who wants a vaccine can get one. This episode is hosted by Phyllis Arthur and features a conversation with Dr. Reed Tuckson, founder of the Black Coalition Against COVID-19.

Hey listeners, it’s been a while. But there’s good reason for that.

Trailing in the polls this fall, President Trump dusted off the 2016 campaign playbook and went after the drug companies again. But channeling anger at the companies the whole world is depending on to end the pandemic was always dicey politics. Post-election, the Trump administration hastily issued a final rule setting Medicare Part B reimbursement rates at the lowest levels charged by counties in the developed world, which ration medicines and leave the sick untreated. BIO took the administration to court, and we won when a federal court issued an injunction blocking the rule.

The diversity of our adaptive immune system is why people are reacting so differently to the novel coronavirus. No two people present the virus the exact same way to their immune systems. We’ve evolved in this way as humans to ensure no virus can eradicate our species.

Hosted by Jim Greenwood.

Millions of travelers ignored public health warnings and packed into airports over the holidays to see their loved ones. As a result, U.S. hospitals are bracing for the deadliest COVID surge yet this month. Meanwhile, Sherlock Biosciences, which has already made history once with CRISPR, seeks to do so again with an inexpensive, accurate home test that could be a global game-changer.